9 Results for "

Lutetium-177

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "Lutetium-177" in MCE Product Catalog:

Cat. No.: HY-P99239
CAS No.: 2260767-49-3
Synonyms: HUJ-591; TLX591

Research Areas:  

Cancer

Rosopatamab (HuJ591) is a humanized antiPSMA IgG1 monoclonal antibody that can be used in cancer research, especially prostate cancer. Rosopatamab can be linked to the low-energy beta-emitting radioisotope lutetium-177 ( 177Lu) through the bifunctional chelator DOTA-NHS ester to obtain a radioimmunoconjugate that targets malignant prostate cells with high efficiency .
loading...
    loading...
Cat. No.: HY-175023A
Target:  

Phosphatase

Research Areas:  

Cancer

OncoACP3 TFA is a small-molecule ligand of prostatic acid phosphatase (ACP3) with an IC50 of 0.30 nM. OncoACP3 TFA has a modular structure that supports flexible payload delivery. After radiolabeling with Lu-177 it selectively accumulates in ACP3-expressing tumors with a long retention time, enabling targeted radiation delivery. OncoACP3 TFA is applicable to research related to prostate cancer .
loading...
    loading...
Cat. No.: HY-175023
CAS No.: 3084147-81-6
Target:  

Phosphatase

Research Areas:  

Cancer

OncoACP3 is a small-molecule ligand of prostatic acid phosphatase (ACP3) with an IC50 of 0.30 nM. OncoACP3 has a modular structure that supports flexible payload delivery. After radiolabeling with Lu-177 it selectively accumulates in ACP3-expressing tumors with a long retention time, enabling targeted radiation delivery. OncoACP3 is applicable to research related to prostate cancer .
loading...
    loading...
Cat. No.: HY-159768A
CAS No.: 2882922-68-9
DOTAGA.Glu.(FAPi) 2 is a FAPI homodimer in which a central glutamic acid (Glu) linker connects FAPI and a chelator. Radiolabeled with gallium- 68, lutetium- 177 or terbium- 161, DOTAGA.Glu.(FAPi) 2 is applicable to FAP-positive cancer PET imaging studies. DOTAGA.Glu.(FAPi) 2 is suitable for research related to prostate adenocarcinoma and recurrent glioblastoma multiforme .
loading...
    loading...
Cat. No.: HY-P11254
Research Areas:  

Cancer

DOTA-FAPT is a novel targeting FAP tracer. DOTA-FAPT can be radiolabeled with gallium-68 and lutetium-177. DOTA-FAPT can be used for PET imaging studies of cancer-associated fibroblasts .
loading...
    loading...
Cat. No.: HY-139551
Target:  

Drug Intermediate

Research Areas:  

Cancer

Guraxetan can be used for the synthesis of antineoplastic lutetium (177Lu) zadavotide Guraxetan .
loading...
    loading...
Cat. No.: HY-161262
CAS No.: 2952588-12-2
Target:  

FAP

Research Areas:  

Cancer

SB03178 is a fibroblast activation protein-alpha (FAP) inhibitor. SB03178 can be conjugated with DOTA and can be used for cancer research .
loading...
    loading...
Cat. No.: HY-P11261
Target:  

PSMA

Research Areas:  

Cancer

AAZTA-NI-PSMA-093 is a bispecific agent targeting prostate-specific membrane antigen (PSMA) with an IC50 value for PSMA of 87.48 nM. AAZTA-NI-PSMA-093 has a PSMA targeting module and an oxygen-sensitivity module (hypoxia-sensitive NI-moiety). AAZTA-NI-PSMA-093 can utilize the PSMA targeting property as a "navigation system" to efficiently concentrate the entire molecule within prostate cancer cells, and once the cells are in an oxygen-deficient state, the molecule will irreversibly capture and remain in the oxygen-deficient cells, achieving "secondary enrichment". AAZTA-NI-PSMA-093 can be labeled with ⁶⁸Ga and ¹⁷⁷Lu, and has high accumulation and rapid clearance characteristics in mouse models. AAZTA-NI-PSMA-093 can be used for the study of prostate cancer .
loading...
    loading...
Cat. No.: HY-P11917
LF1 is a gastrin-releasing peptide receptor (GRPR) antagonist. LF1 can be stably radiolabeled with gallium- 68, indium- 111, and lutetium- 177. Radiolabeled LF1 can be used for high-contrast SPECT/CT imaging. LF1 is applicable to prostate cancer-related research .
loading...
    loading...